Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 3 countries.
Elizabeth Ruiz-MárvezGrupo de Investigación en Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Carrera 7 # 40- 62, Bogotá, Colombia.ORCID 0000-0003-1949-4736
César Augusto RamírezGrupo de Investigación en Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Carrera 7 # 40- 62, Bogotá, Colombia.
Eliana Rocío RodríguezGrupo de Investigación en Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Carrera 7 # 40- 62, Bogotá, Colombia.ORCID 0000-0001-5511-9402
Magda Mellisa FlórezGrupo de Investigación en Inmunotoxicología, Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Carrera 30 # 45-01, Bogota, Colombia.ORCID 0000-0002-5751-9773
Gabriela DelgadoGrupo de Investigación en Inmunotoxicología, Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Carrera 30 # 45-01, Bogota, Colombia.ORCID 0000-0003-2947-7796
Fanny GuzmánNúcleo de Biotecnología Curauma (NBC), Pontificia Universidad Católica de Valparaiso, Avenida Universidad, Curauma, Valparaiso 2373223, Chile.ORCID 0000-0002-7829-0568
Paulino Gómez-PuertasGrupo de Modelado Molecular del Centro de Biología Molecular Severo Ochoa, Microbes in Health and Welfare Department, Universidad Autónoma de Madrid (CBMSO, CSIC-UAM), 28049 Madrid, Spain.ORCID 0000-0003-3131-729X
José María RequenaGrupo Regulación de la Expresión Génica en Leishmania del Centro de Biología Molecular Severo Ochoa, Molecular Biology Department, Universidad Autónoma de Madrid (CBMSO, CSIC-UAM), 28049 Madrid, Spain.ORCID 0000-0001-7550-0198
Concepción J PuertaGrupo de Investigación en Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Carrera 7 # 40- 62, Bogotá, Colombia.ORCID 0000-0002-3449-3961
Pontificia Universidad Javeriana · COCentro de Biología Molecular Severo Ochoa · ESUniversidad Nacional de Colombia · COPontificia Universidad Católica de Valparaíso · CL
Funding
Federación Española de Enfermedades Raras RTI2018-094434-B-I00Instituto de Salud Carlos III RD16/0027/0008Ministerio de Ciencia y Tecnología 120356933228
6 · The paper itself
Abstract
The Tc964 protein was initially identified by its presence in the interactome associated with the LYT1 mRNAs, which code for a virulence factor of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Molecular Characterization of Tc964, A Novel Antigenic Protein from · full record | OpenQuestion